Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 4/21/25 → 4/21/27 |
Funding
- Janssen Research and Development LLC: $2.00
25-GU-87-JJ (42756493BLC0013): Phase 1/2 Study of Erdafitinib Intravesical Delivery System (TAR-210) in Participants with Non-Muscle-Invasive or Muscle-Invasive Bladder Cancer
- Hensley, Patrick (PI)